Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Deutsche Boerse AG  >  Canntab Therapeutics Limited    TBF1   CA1377991023

CANNTAB THERAPEUTICS LIMITED

(TBF1)
  Report
 SummaryQuotesChartsNewsCompanyFinancials 
Quotes 5-day view   Delayed Quote. Delayed Deutsche Boerse Ag
01/20/2021 01/21/2021 01/22/2021 01/25/2021 01/26/2021 Date
0.454(c) 0.474(c) 0.492(c) 0.496(c) 0.482(c) Last
0 0 0 0 0 Volume
-2.58% +4.41% +3.80% +0.81% -2.82% Change
More quotes
Financials
Sales 2019 0,24 M 0,19 M 0,19 M
Net income 2019 -2,46 M -1,94 M -1,94 M
Net cash position 2019 1,59 M 1,25 M 1,25 M
P/E ratio 2019 -7,51x
Yield 2019 -
Sales 2020 0,13 M 0,10 M 0,10 M
Net income 2020 -2,61 M -2,05 M -2,05 M
Net cash position 2020 1,36 M 1,07 M 1,07 M
P/E ratio 2020 -10,2x
Yield 2020 -
Capitalization 27,4 M 21,5 M 21,6 M
EV / Sales 2019 70,4x
EV / Sales 2020 231x
Nbr of Employees -
Free-Float 76,0%
More Financials
Company
Canntab Therapeutics Ltd, formerly Telferscot Resources Inc, is a Canada-based company engaged in alternatywe medicine sector. The Company is dedicated to the research and development of oral dosage therapeutic formulations of cannabis and a range of oral dosage products that treat different ailments by delivering a uniform dosage of medicinal cannabis extract. The Company developed bi-layered tablets that offer an... 
Sector
Pharmaceuticals
Calendar
-
More about the company
All news about CANNTAB THERAPEUTICS LIMITED
2020Canntab Announces Closing of Convertible Debenture Private Placement
NE
2020CANNTAB THERAPEUTICS : Begins Delivery of Tablets to MediPharm
PR
2020Canntab Therapeutics Announces End of Supply and Distribution Agreements with..
NE
2020CANN GLOBAL : Canntab to Launch in Australia and Participate in Australia's Larg..
AQ
2020CANNTAB THERAPEUTICS : to Launch in Australia and Participate in Australia's Lar..
PR
2020Canntab Announces Closing of Purchases of Cannabis Processing Equipment and L..
NE
2020CANNTAB THERAPEUTICS : IIROC Trade Resumption - PILL
AQ
2020CANNTAB THERAPEUTICS : Granted 1st US Patent Covering Multi-Layer (Bi-Layer) Tab..
AQ
2020CANNTAB THERAPEUTICS : Granted 1st US Patent Covering Multi-Layer (Bi-Layer) Tab..
PR
2020CANNTAB THERAPEUTICS : IIROC Trading Halt - PILL
AQ
2020CANNTAB THERAPEUTICS : announces planned purchases of cannabis processing equipm..
AQ
2020CANNTAB THERAPEUTICS : Appoints Larry Latowsky as CEO
AQ
2020CANNTAB THERAPEUTICS : IIROC Trade Resumption - PILL
AQ
2020CANNTAB THERAPEUTICS : and Medipharm Labs Enter Into a Wholesale Tablet Purchase..
AQ
2020CANNTAB THERAPEUTICS : IIROC Trading Halt - PILL
AQ
More news
News in other languages on CANNTAB THERAPEUTICS LIMITED
2018IRW-NEWS : Canntab Therapeutics Ltd.: Canntab announces collaboration and profit..
More news
Chart CANNTAB THERAPEUTICS LIMITED
Duration : Period :
Canntab Therapeutics Limited Technical Analysis Chart | MarketScreener
Full-screen chart
Income Statement Evolution
Managers and Directors
NameTitle
Lawrence Latowsky Executive Chairman & Chief Executive Officer
Jeffrey W. Renwick President, Director & Head-Manufacturing
Richard Goldstein Chief Financial Officer & Director
Joshi Laxminarayan Chief Scientific Officer
Vitor Manuel Fonseca Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
CANNTAB THERAPEUTICS LIMITED-1.23%22
CANOPY GROWTH CORPORATION33.62%12 566
CURALEAF HOLDINGS, INC.24.41%10 291
BEIJING TONGRENTANG CO., LTD3.85%5 253
TRULIEVE CANNABIS CORP.37.44%5 133
APHRIA INC.73.98%4 089